Concord Medical Co., Ltd. (TPEX:6518)
27.30
-0.05 (-0.18%)
At close: Mar 27, 2026
Concord Medical Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 125.18 | 109.75 | 111.26 | 246.91 | 198.8 |
Short-Term Investments | - | 211.5 | 209 | 100 | - |
Cash & Short-Term Investments | 125.18 | 321.25 | 320.26 | 346.91 | 198.8 |
Cash Growth | -61.03% | 0.31% | -7.68% | 74.50% | 234.55% |
Accounts Receivable | 303.15 | 301.6 | 306.75 | 314.22 | 310.82 |
Other Receivables | - | 0.56 | 3.13 | 7.62 | 9.6 |
Receivables | 303.15 | 302.15 | 309.88 | 321.85 | 320.42 |
Inventory | 9.36 | 3.98 | 2.56 | 6.19 | 9.37 |
Prepaid Expenses | 6.14 | 3.61 | 5.64 | 3.21 | 2.93 |
Other Current Assets | 158 | - | - | - | 2.77 |
Total Current Assets | 601.83 | 631 | 638.34 | 678.17 | 534.29 |
Property, Plant & Equipment | 136.82 | 149.82 | 136.64 | 117.75 | 526.83 |
Long-Term Investments | 114.93 | 20 | - | - | - |
Other Intangible Assets | 21.07 | 2.65 | 2.63 | 1.95 | 1.76 |
Long-Term Accounts Receivable | - | 3.34 | 4.63 | 0.96 | - |
Long-Term Deferred Tax Assets | 4.72 | 0.26 | 0.29 | 0.54 | 0.4 |
Other Long-Term Assets | 341.21 | 356.74 | 369.13 | 375.84 | 18.73 |
Total Assets | 1,221 | 1,164 | 1,152 | 1,176 | 1,083 |
Accounts Payable | 245.24 | 235.04 | 230.72 | 245.86 | 228.03 |
Accrued Expenses | - | 0.37 | 0.28 | - | - |
Short-Term Debt | 25.85 | - | - | - | - |
Current Portion of Leases | 30.2 | 25.41 | 23.05 | 20.49 | 18.48 |
Current Income Taxes Payable | 8.53 | 7.43 | 4.68 | 9.74 | 5.52 |
Current Unearned Revenue | - | - | 0.04 | 2.21 | 0.04 |
Other Current Liabilities | 27.5 | 17.28 | 23.78 | 20.43 | 16.7 |
Total Current Liabilities | 337.32 | 285.53 | 282.54 | 298.72 | 268.77 |
Long-Term Debt | - | 35 | 35 | - | - |
Long-Term Leases | 122.37 | 141.46 | 148.63 | 160.43 | 171.68 |
Long-Term Deferred Tax Liabilities | 2.24 | - | - | - | - |
Other Long-Term Liabilities | 4.52 | 4.54 | 4.54 | 4.91 | 4.8 |
Total Liabilities | 466.45 | 466.53 | 470.71 | 464.06 | 445.25 |
Common Stock | 333.33 | 333.33 | 333.33 | 333.33 | 333.33 |
Additional Paid-In Capital | 179.22 | 179.22 | 179.22 | 179.22 | 179.22 |
Retained Earnings | 215.41 | 184.71 | 169.23 | 159.82 | 125.83 |
Comprehensive Income & Other | - | - | -0.75 | -0.75 | -0.75 |
Total Common Equity | 727.96 | 697.26 | 681.03 | 671.62 | 637.63 |
Minority Interest | 26.17 | - | - | 39.98 | - |
Shareholders' Equity | 754.13 | 697.26 | 681.03 | 711.6 | 637.63 |
Total Liabilities & Equity | 1,221 | 1,164 | 1,152 | 1,176 | 1,083 |
Total Debt | 178.42 | 201.87 | 206.68 | 180.92 | 190.16 |
Net Cash (Debt) | -53.24 | 119.37 | 113.58 | 165.99 | 8.64 |
Net Cash Growth | - | 5.10% | -31.57% | 1822.12% | - |
Net Cash Per Share | -1.59 | 3.57 | 3.40 | 4.97 | 0.34 |
Filing Date Shares Outstanding | 33.36 | 33.33 | 33.33 | 33.33 | 33.33 |
Total Common Shares Outstanding | 33.36 | 33.33 | 33.33 | 33.33 | 33.33 |
Working Capital | 264.51 | 345.47 | 355.8 | 379.45 | 265.52 |
Book Value Per Share | 21.82 | 20.92 | 20.43 | 20.15 | 19.13 |
Tangible Book Value | 706.89 | 694.62 | 678.39 | 669.67 | 635.86 |
Tangible Book Value Per Share | 21.19 | 20.84 | 20.35 | 20.09 | 19.08 |
Land | - | - | - | - | 169.14 |
Buildings | - | - | - | - | 49.02 |
Machinery | - | 284.31 | 237.56 | 205.29 | 273.95 |
Construction In Progress | - | 1.38 | 3.6 | 2.71 | 0.96 |
Leasehold Improvements | - | 48.32 | 55.47 | 73.3 | 86.73 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.